Growth Metrics

Repligen (RGEN) Change in Accured Expenses (2016 - 2025)

Repligen (RGEN) has disclosed Change in Accured Expenses for 16 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 192.76% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.8 million, a 93.47% increase, with the full-year FY2025 number at $11.8 million, up 93.47% from a year prior.
  • Change in Accured Expenses was $2.2 million for Q4 2025 at Repligen, down from $12.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $13.1 million in Q4 2021 to a low of -$10.0 million in Q1 2022.
  • A 5-year average of $878900.0 and a median of $1.3 million in 2024 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: surged 563.32% in 2021, then crashed 566.02% in 2025.
  • Repligen's Change in Accured Expenses stood at $13.1 million in 2021, then crashed by 138.51% to -$5.1 million in 2022, then tumbled by 77.87% to -$9.0 million in 2023, then surged by 108.29% to $746000.0 in 2024, then soared by 192.76% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Change in Accured Expenses are $2.2 million (Q4 2025), $12.6 million (Q3 2025), and -$4.8 million (Q2 2025).